• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Franklin UK Opportunities Fund W Inc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Franklin Templeton Investments (UK)
Fund Summary Aims to achieve a total return (i.e. a combination of capital growth and income) exceeding that of the FTSE All-Share Index, over the medium to long term (meaning 3-5 years)
SEDOL code BYVDZT9
ISIN GB00BYVDZT91
Fund code BWIGW
Managers Ben Russon, Colin Morton, Mark Hall
Manager Tenure 7 years
Morningstar Category UK Large-Cap Equity
IMA Sector UK All Companies
Fund Size £39 million
Fund Type OEIC
Management Style Active
Ongoing Charge Figure (OCF) 0.55%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £0.9272
Buy Price £0.9272
Price Change -1.4979%
Price Date 8th April 2020
Yield 3.60%
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 28th September 2015
Fund Status OPEN
Ben Russon is a fund manager based in Leeds as part of Franklin Templeton Fund Management. He is the lead manager on the Franklin UK Select Growth Fund and Co-Manager on the Franklin UK Managers' Focus Fund. Mr. Russon joined the Franklin Templeton UK Equity team during 2013. Prior to this he spent 13 years as a Fund Manager with Newton Investment Management, specialising in UK Equities. He was the lead manager on the Newton UK Opportunities Fund from 2005, alongside associated institutional mandates. Mr. Russon had prior experience at Newton in the research function, specialising in the global food retail sector. Wider responsibilities also included global equity investment with the Newton Osprey Fund. Mr. Russon graduated from the University of Edinburgh with an M.A. (joint honours) in geography and economics. He is a Chartered. Financial Analyst (CFA) Charterholder.

3-year Mean Monthly Return: -0.217%

Annual Returns 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund Performance -16.05% +5.22% +1.21% +13.11% +0.70% +8.35% +9.24% +16.62% +0.80% +11.16%
Benchmark Performance
(UK Large-Cap Equity)
-18.97% +5.09% +0.61% +18.76% -3.91%
Time Period Cumulative Benchmark Performance
(UK Large-Cap Equity)
Fund Compared to Benchmark
1 day -1.50% -25.65% +24.15%
1 week 3.26% -13.94% +17.21%
1 month -15.15% -25.69% +10.54%
3 months -24.78% -19.73% -5.05%
6 months -18.79% -20.59% +1.80%
1 year -17.29% -5.04% -12.25%
3 years -3.36% -0.92% -2.44%
5 years 0.05% +4.25% -4.19%
10 years 4.63% +5.08% -0.45%
YTD -24.46% +3.66% -28.12%
Since inception 8.56% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
AstraZeneca PLC GBR 4.60%
BP PLC GBR 4.47%
Royal Dutch Shell PLC Class A GBR 4.41%
GlaxoSmithKline PLC GBR 4.38%
British American Tobacco PLC GBR 3.70%
RELX PLC GBR 3.54%
Diageo PLC GBR 3.49%
Unilever PLC GBR 3.33%
Smith & Nephew PLC GBR 2.91%
National Grid PLC GBR 2.89%
Dividend Date Per share amount Reinvestment Price
1st April 2020 0.0185 £0.8979
1st October 2019 0.0231 £1.1863
1st April 2019 0.0190 £1.1413
1st October 2018 0.0219 £1.1818
3rd April 2018 0.0158 £1.1111
2nd October 2017 0.0261 £1.1718